Societal cost-effectiveness analysis of the 21-gene assay in early-stage breast cancer in Japan

"The 21-gene assay for women with estrogen-receptor–positive, lymph-node–negative, early-stage breast cancer is projected to be cost-effective in Japan."

Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan
H Yamauchi et al.
BMC Health Services Research 2014, 14:372

Read more here.

Genomic technology in healthcare

"This report sets out a strategic vision for how the healthcare system in the UK – and particularly in the NHS – can benefit from the mainstream adoption of genomic technology."

Building on our inheritance: genomic technology in healthcare
Human Genomics Strategy Group
January 2012

Read more here.